^(18)F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N-and M-staging:should guidelines recommend it at last?
作者机构:Surgical Oncology UnitAzienda UnitàSanitaria Locale-IRCCS di Reggio EmiliaArcispedale Santa Maria Nuova di Reggio EmiliaReggio EmiliaItaly Pathology UnitAzienda UnitàSanitaria Locale-IRCCS di Reggio EmiliaArcispedale Santa Maria Nuova di Reggio EmiliaReggio EmiliaItaly Pathology UnitAzienda Ospedaliero-UniversitariaOspedali Riuniti di FoggiaFoggiaItaly Nuclear Medicine UnitAzienda UnitàSanitaria Locale-IRCCS di Reggio EmiliaArcispedale Santa Maria Nuova di Reggio EmiliaReggio EmiliaItaly Radiology UnitAzienda UnitàSanitaria Locale-IRCCS di Reggio EmiliaArcispedale Santa Maria Nuova di Reggio EmiliaReggio EmiliaItaly
出 版 物:《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养(英文))
年 卷 期:2022年第11卷第5期
页 面:789-792页
核心收录:
学科分类:07[理学] 070202[理学-粒子物理与原子核物理] 0702[理学-物理学]
基 金:supported by Italian Ministry of Health-Ricerca Corrente Annual Program 2023
摘 要:We really appreciated Lin et al.’s“The influence of ^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography on the N-and M-staging and subsequent clinical management of intrahepatic cholangiocarcinomain HepatoBiliary Surgery and Nutrition(1).A 291-patient population affected by intrahepatic cholangiocarcinoma(ICC)was retrospectively analyzed with the aim of assessing the accuracy of preoperative staging and treatment reallocation by ^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography(^(18)F-FDG PET/CT)(1).